Aberrant miRNA and mRNA expression profiles were detected in different cancer entities and MYC was shown to upregulate, among others, the oncomiR miR-17-92 cluster [31,32,37], whereas an association to the cytogenetic status, especially 1q gains, was not reported. Here, MYC is linked to cancer.